Effective alternatives in the face of a growing problem

Journal of the American Academy of Physician Assistants

Volumn 26, Issue 2, 2013, Pages 13-18

  Borchardt, Roy A ^a   Rolston, Kenneth V I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; FOSCARNET; MEROPENEM; THIENAMYCIN DERIVATIVE;

ARTICLE; DRUG REPOSITIONING; DRUG SUBSTITUTION; HUMAN; INFECTION;

ANTI-INFECTIVE AGENTS; DRUG REPOSITIONING; DRUG SUBSTITUTION; FOSCARNET; HUMANS; INFECTION; THIENAMYCINS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

MLCS; MLOWN;

EID: 84875791322     PISSN: 15471896     EISSN: 08937400     Source Type: Journal    
DOI: 10.1097/01720610-201302000-00004     Document Type: Article

References (8)

1. Chabner BA. Drug shortages-a critical challenge for the generic-drug market. N Engl J Med. 2011;365(23):2147-2149.
2. Kaiser J. Shortages of cancer drugs put patients, trials at risk. Science. 2011;332(6029):523.
3. Griffith MM, Gross AE, Sutton SH, et al. The impact of anti- infective drug shortages on hospitals in the United States: trends and causes. Clin Infect Dis. 2012;54(5):684-691.
4. Griffith MM, Pentoney Z, Scheetz MH. Antimicrobial drug shortages: a crisis amidst the epidemic and the need for antimicrobial stewardship efforts to lessen the effects. Pharmacotherapy. 2012;32:665-667.
5. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 2007;45(12):1602-1609.
6. Helweg-Larsen J, Benfield T, Atzori C, Miller RF. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. J Antimicrob Chemother. 2009;64(6):1282-1290.
7. Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program. 2011;2011(1):305-309.
8. Legrand M, Max A, Schlemmer B, et al. The strategy of antibiotic use in critically ill neutropenic patients. Ann Intensive Care. 2011;1(1):22.